Latest Umbilical cord Stories
HONG KONG, June 6, 2012 /PRNewswire-Asia-FirstCall/ -- China Cord Blood Corporation (NYSE: CO) ("the Company") today announced its plan to release financial results for the fourth quarter and full year of fiscal year 2012 on Monday, June 11, 2012, after market close in the US. The Company will host a conference call at 8:00 a.m. ET on Tuesday, June 12, 2012 to discuss its financial performance and give a brief overview of the Company's recent developments, followed by a question...
SHENZHEN, China, May 29, 2012 /PRNewswire-Asia/ -- Beike Biotechnology Co., Ltd ("Beike") announced that it has been awarded AABB accreditation for cord blood and cord tissue banking. This accreditation has been granted following an intensive on-site assessment by AABB assessors and establishes that the level of medical, technical and administrative performance within the facility is in accordance with the AABB standards or exceeds those set by AABB. With this achievement,...
LAS VEGAS, May 21, 2012 /PRNewswire/ -- Cord Blood America, Inc. (www.cordblood-america.com) (OTC Bulletin Board: CBAI), the umbilical cord blood stem cell preservation company focused on bringing the life saving potential of stem cells to families nationwide and internationally, today announced that revenues for the first quarter of 2012 increased by 6.7% to $1.55 million compared to $1.45 in the same period last year. The Company announced a gross profit of $1.12 million in the...
SAN FRANCISCO, May 16, 2012 /PRNewswire/ -- The Newborn Possibilities Fund, a grant making program established by CBR (Cord Blood Registry), today announced it has provided a grant to the Memorial Hermann Foundation in Houston, Texas. Children's Memorial Hermann Hospital and CBR are conducting the first FDA-regulated, Phase 1 safety study of the use of cord blood stem cells to treat children with sensorineural hearing loss. The grant will provide financial support to help with...
LAS VEGAS, May 15, 2012 /PRNewswire/ -- Cord Blood America, Inc. (www.cordblood-america.com) (OTC BB: CBAI), the umbilical cord blood stem cell preservation company focused on bringing the life saving potential of stem cells to families nationwide and internationally, today announced that, effective May 14, 2012, Matthew Schissler has resigned his position as Chairman, CEO, and Secretary, and as a Director of Cord Blood America. Mr. Schissler is also no longer an officer or...
Win The New iPad and Cord Blood Banking at No Cost with Americord by Attending New York Baby Show on Saturday and Sunday May 19 and 20, 2012. New York, NY (PRWEB) April 15, 2012 Americord announced today that attendees visiting the company's exhibitor booth at the New York Baby Show, an event for new and expecting parents being held in New York, May 19 and 20, will have a chance to win the New iPad, and free cord blood banking, all at no cost. The drawing will be Monday, May 21 and the...
LAS VEGAS, April 16, 2012 /PRNewswire/ -- Cord Blood America, Inc. (www.cordblood-america.com) (OTC Bulletin Board: CBAI), the umbilical cord blood stem cell preservation company focused on bringing the life saving potential of stem cells to families nationwide and internationally, today announced that revenues for 2011 increased 37 percent to $5.67 million compared to $4.13 million in 2010. The Company announced a gross profit increase in 2011 of $1.3 million, or 52...
NEW YORK, April 12, 2012 /PRNewswire/ -- Gathering together some of the world's most prominent researchers in the field of cord blood biology, the New York Blood Center (NYBC) hosted the "Second Milstein Symposium: Perspectives in Cord Blood Biology and Clinical Applications" at NYBC's Murray Sargent Auditorium. (Photo: http://photos.prnewswire.com/prnh/20120412/NY86569 ) Tuesday's day-long symposium, attended by more than 200 doctors, scientists and others in the...
Americord CEO explains how the company delivers cord blood and cord tissue banking at significantly lower prices than ViaCord or CBR New York, NY (PRWEB) April 02, 2012 Americord Registry, a leader in the advancement of cord blood, cord tissue and placenta banking, announced today it is making cord blood and cord tissue banking available at prices approximately 50% lower than those of other cord blood industry leaders, including ViaCord and CBR. A detailed comparison of the costs for cord...
RANCHO CORDOVA, Calif., March 29, 2012 /PRNewswire/ -- ThermoGenesis Corp. (NASDAQ: KOOL), a leading supplier of innovative products and services that process and store adult stem cells, said today that its customer Beike Biotechnology Co., Ltd. (Beike) has become the first company in China to receive accreditation from the AABB (formerly the American Association of Blood Banks). AABB is an international, not-for-profit association representing nearly 2,000 institutions and 8,000...
